Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.180 AUD
−14.00 M AUD
0.00 AUD
56.78 M
About ARTRYA LIMITED
Sector
Industry
CEO
Mathew Regan
Website
Headquarters
West Perth
Founded
2018
ISIN
AU0000182412
FIGI
BBG0133J6Y06
Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). It uses artificial intelligence (AI) to improve the detection and management of coronary artery disease. The company was founded by John Windsor Barrington and John Konstantopoulos on January 24, 2018 and is headquartered in West Perth, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AYA is 0.570 AUD — it has increased by 17.53% in the past 24 hours. Watch ARTRYA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ARTRYA LIMITED stocks are traded under the ticker AYA.
AYA stock has risen by 17.53% compared to the previous week, the month change is a 29.55% rise, over the last year ARTRYA LIMITED has showed a 165.12% increase.
AYA stock is 17.17% volatile and has beta coefficient of −0.49. Track ARTRYA LIMITED stock price on the chart and check out the list of the most volatile stocks — is ARTRYA LIMITED there?
Yes, you can track ARTRYA LIMITED financials in yearly and quarterly reports right on TradingView.
ARTRYA LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
AYA net income for the last half-year is −7.12 M AUD, while the previous report showed −6.88 M AUD of net income which accounts for −3.52% change. Track more ARTRYA LIMITED financial stats to get the full picture.
No, AYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARTRYA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARTRYA LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARTRYA LIMITED stock shows the buy signal. See more of ARTRYA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.